Standby Emergency Treatment of Malaria in Travelers

Experience to Date and New Developments

Patricia Schlagenhauf; Eskild Petersen


Expert Rev Anti Infect Ther. 2012;10(5):537-546. 

In This Article

Situations Where Carriage of SBET May Be Indicated

This SBET option is not intended to replace chemoprophylaxis at high-risk destinations such as sub-Saharan Africa or to detract from the importance of medical consultation when suspected malaria occurs.

The strategy could be recommended for the following situations:

  • Travelers visiting an area with a minimal malaria risk and/or a remote area far from medical attention. The authors favor that a definition of minimal risk of malaria be defined as fewer than ten cases per year per 1000 population,[1] but this definition can be debated. Accurate information on malaria risk at traveler destinations is still largely incomplete, and more information is needed on the true risk of acquiring malaria in the absence of chemoprophylaxis. The risk of infection is also influenced by the behavior of the traveler. The carriage of an emergency malaria treatment as a stand alone strategy is predominantly recommended in Germany, Switzerland and Austria;[1,14]

  • Expatriates or long-term travelers who are likely to have gaps in chemoprophylaxis adherence;

  • Travelers who are likely to have a changing itinerary with different malaria risks (e.g., backpackers);

  • The short-stay, frequent traveler (e.g., aircrews and business travelers);

  • Travelers visiting destinations without qualified medical services. The term 'qualified medical service' encompasses the ability to provide correct and prompt diagnosis, clinical assessment and correct treatment with proper quality drugs.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: